CN109430862A - 一种具有降血脂功能的口服液的制作方法 - Google Patents
一种具有降血脂功能的口服液的制作方法 Download PDFInfo
- Publication number
- CN109430862A CN109430862A CN201811036616.9A CN201811036616A CN109430862A CN 109430862 A CN109430862 A CN 109430862A CN 201811036616 A CN201811036616 A CN 201811036616A CN 109430862 A CN109430862 A CN 109430862A
- Authority
- CN
- China
- Prior art keywords
- potato
- orange
- hericium erinaceus
- filtrate
- oral solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229940100688 oral solution Drugs 0.000 title claims abstract description 15
- 230000000055 hyoplipidemic effect Effects 0.000 title claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 17
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 17
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 12
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 238000000855 fermentation Methods 0.000 claims abstract description 9
- 230000004151 fermentation Effects 0.000 claims abstract description 9
- 235000015205 orange juice Nutrition 0.000 claims abstract description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 8
- 239000000706 filtrate Substances 0.000 claims abstract description 8
- 235000016709 nutrition Nutrition 0.000 claims abstract description 8
- 230000035764 nutrition Effects 0.000 claims abstract description 8
- 239000002002 slurry Substances 0.000 claims abstract description 8
- 241000289669 Erinaceus europaeus Species 0.000 claims abstract description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 5
- 239000008103 glucose Substances 0.000 claims abstract description 5
- 239000000047 product Substances 0.000 claims abstract description 5
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- 241000233866 Fungi Species 0.000 claims abstract description 4
- 230000001580 bacterial effect Effects 0.000 claims abstract description 4
- 239000000084 colloidal system Substances 0.000 claims abstract description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims abstract description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims abstract description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 claims abstract description 4
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000013606 potato chips Nutrition 0.000 claims abstract description 4
- 238000007789 sealing Methods 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000035622 drinking Effects 0.000 abstract description 3
- 235000009508 confectionery Nutrition 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 235000001727 glucose Nutrition 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 150000003626 triacylglycerols Chemical class 0.000 description 9
- 235000012000 cholesterol Nutrition 0.000 description 8
- 229930003944 flavone Natural products 0.000 description 8
- 235000011949 flavones Nutrition 0.000 description 8
- 108010023302 HDL Cholesterol Proteins 0.000 description 7
- 150000002213 flavones Chemical class 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 108010007622 LDL Lipoproteins Proteins 0.000 description 5
- 102000007330 LDL Lipoproteins Human genes 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- 201000005577 familial hyperlipidemia Diseases 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- 102000015779 HDL Lipoproteins Human genes 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 108010084210 citrin Proteins 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000577951 Hydnum Species 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- -1 flavone glycoside Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/24—Synthetic spices, flavouring agents or condiments prepared by fermentation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种具有降血脂功能的口服液的制作方法，属于保健食品加工技术领域。把马铃薯洗净去皮,切成土豆片,加水煮沸半小时后过滤得滤液，在滤液中加入葡萄糖、磷酸二氢钾、硫酸镁，搅拌溶解得马铃薯提取液，将橙子榨汁得橙汁，将马铃薯提取液和橙汁混合均匀，灭菌10分钟，降温到22‑28℃，接入猴头菇菌种，培养80‑96小时得猴头菇发酵液，猴头菇发酵液经菌丝体胶体磨磨浆得营养浆液，营养浆液再经过滤、调配、浓缩、灌装、封口、灭菌即得成品。本发明的口服液不仅口感好、果香浓郁、饮用安全，而且具有显著的降血脂功效。
Description
技术领域
本发明公开了一种具有降血脂功能的口服液的制作方法，属于保健食品加工技术领域。
背景技术
随着现代人生活水平的提高以及饮食结构的改变，高血脂症的病人越来越多, 高血脂症是指高胆固醇、高甘油三脂、极低密度脂蛋白增高和高密度脂蛋白降低的脂蛋白代谢异常性疾病，高血脂症是动脉粥样硬化、冠心病、高血压、糖尿病的危险因素，严重威胁着人类身体健康。高血脂症是一种很顽固的慢性疾病，不是一朝一夕就能治好的，对于高血脂症患者，除了要改变日常生活中的饮食、生活方式外，还需要进行药物治疗，但是所有降脂药都有一定的副作用。所以，近年来利用天然食用原料加工成食用安全的降血脂产品成了本领域科研工作者研究的热点。
发明内容
本发明的目的是提供一种口感好、果香浓郁、饮用安全的具有降血脂功能的口服液的制作方法。
本发明的目的是这样实现的：
把马铃薯洗净去皮,取180-220克切成4-5毫米厚的土豆片,加水1000毫升,煮沸半小时后过滤得滤液，在滤液中加入20g葡萄糖，2g磷酸二氢钾，1g 硫酸镁，搅拌溶解并定容至1000毫升得马铃薯提取液。
将橙子榨汁得橙汁，按照质量比1:1的比例将马铃薯提取液和橙汁混合均匀，在90-95℃条件下灭菌10分钟，降温到22-28℃，从斜面上接入猴头菇菌种，在22-28℃、160-200rpm的条件下摇床培养80-96小时得猴头菇发酵液，猴头菇发酵液经菌丝体胶体磨磨浆得营养浆液，营养浆液再经过滤、调配、浓缩、灌装、封口、灭菌即得成品。
本发明的口服液有益效果包括以下几个方面：
第一，本发明的口服液的原料经过了猴头菇的发酵作用，猴头菇代谢产生大量的猴头菇多糖，猴头菇多糖能降低血清中甘油三酯和总胆固醇的含量，具有明显的降血脂作用，另外，猴头菇多糖还有保护胃黏膜和保护肝脏的作用，高血脂症患者很多都同时伴有高血压和高血糖的症状，猴头菇多糖可以减少降压药和降糖药对胃和肝脏的损害。
第二，本发明的口服液所用原料都是天然食材，不含药物成分，对人体没有副作用，食用是安全的。
第三，本发明的口服液的原料含有橙子，橙子中丰富的维生素P能增强毛细血管壁的弹性，对高脂血症有益，橙子中所含的黄酮和柠檬素成分可以增加血液中高密度脂蛋白含量，降低低密度脂蛋白的含量，另外，橙子中的黄酮大部分以糖苷的形式存在，不易被人体吸收，猴头菇代谢产生的β-葡萄糖苷酶可以将橙子中的糖苷型黄酮转化成苷元型黄酮，苷元型黄酮不仅易被人体吸收，而且其生理活性也比其相应的糖苷型黄酮高，经过测定，本发明实施例的口服液中黄酮糖苷转化成黄酮苷元的转化率为90%。
第四，本发明的口服液具有浓郁的果香，橙汁经过猴头菇发酵后，猴头菇代谢产生的β-葡萄糖苷酶可以将橙子中的结合态呈香物质转化成游离态呈香物质，增加本发明口服液的香气。
具体实施方式
本发明采用的猴头菌CICC50081采购于中国工业微生物菌种保藏管理中心。
把马铃薯洗净去皮,取200克切成4-5毫米厚的土豆片,加水1000毫升,煮沸半小时后过滤得滤液，在滤液中加入20g葡萄糖，2g磷酸二氢钾，1g 硫酸镁，搅拌溶解并定容至1000毫升得马铃薯提取液。
将橙子榨汁得橙汁，按照质量比1:1的比例将马铃薯提取液和橙汁混合均匀，在90℃条件下灭菌10分钟，降温到25℃，从斜面上接入猴头菇菌种，在25℃、180rpm的条件下摇床培养88小时得猴头菇发酵液，猴头菇发酵液经菌丝体胶体磨磨浆得营养浆液，营养浆液再经过滤、调配、浓缩、灌装、封口、灭菌即得成品。
本发明降血脂口服液实施效果试验：
筛选体检血脂四项 ( TC、TG、HDL-C、LDL-C )中有1-4项异常的受试者20人，让这20位受试者饮用本发明实施例的降血脂口服液，试验时间为60天，试验期间每天早饭后和晚饭后各饮用50毫升，这期间不服用降血脂类药物，60天后，测定其血液中TC、TG、HDL-C、LDL-C浓度，并与饮用本发明降血脂口服前体检情况进行比较，结果显示，受试者总胆固醇( TC )平均下降了18.11%，甘油三酯( TG ) 平均降低15.33%，低密度脂蛋白胆固醇(LDL-C) 平均降低21.49%，高密度脂蛋白胆固醇(HDL-C) 平均升高了8.34%，从以上数据可以看出，本发明的口服液具有明显的降血脂功效，同时本发明的降血脂口服液还可以提高高密度脂蛋白胆固醇(HDL-C)的含量，高密度脂蛋白胆固醇(HDL-C) 对血管有保护作用，可以大大降低冠心病发病几率。
以下举例说明 ：
周×，男，46 岁，体检时总胆固醇、低密度脂蛋白、甘油三酯三项都超标，320排冠脉CT显示右冠状动脉非钙化及钙化斑块，官腔狭窄25-49%，伴有胸闷、气短、活动后喘憋等症状，试验期间每天早饭后和晚饭后各饮用本发明实施例的口服液50毫升，连续饮用60天后，复查时总胆固醇、低密度脂蛋白、甘油三酯都恢复正常水平，胸闷、气短、活动后喘憋等症状消失。
孙××，女，51岁，体检时总胆固醇、低密度脂蛋白、甘油三酯三项都超标，同时患有2型糖尿病，试验期间每天早饭后和晚饭后各饮用本发明实施例的口服液50毫升，连续饮用60天后，复查时总胆固醇、低密度脂蛋白、甘油三酯都恢复正常水平，同时血糖指标也得到明显改善。
Claims (1)
1.一种具有降血脂功能的口服液的制作方法，其特征是经过如下加工过程制备而成：
⑴把马铃薯洗净去皮,取180-220克切成4-5毫米厚的土豆片,加水1000毫升,煮沸半小时后过滤得滤液，在滤液中加入20g葡萄糖，2g磷酸二氢钾，1g 硫酸镁，搅拌溶解并定容至1000毫升得马铃薯提取液；
⑵将橙子榨汁得橙汁，按照质量比1:1的比例将马铃薯提取液和橙汁混合均匀，在90-95℃条件下灭菌10分钟，降温到22-28℃，从斜面上接入猴头菇菌种，在22-28℃、160-200rpm的条件下摇床培养80-96小时得猴头菇发酵液，猴头菇发酵液经菌丝体胶体磨磨浆得营养浆液，营养浆液再经过滤、调配、浓缩、灌装、封口、灭菌即得成品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811036616.9A CN109430862A (zh) | 2018-09-06 | 2018-09-06 | 一种具有降血脂功能的口服液的制作方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811036616.9A CN109430862A (zh) | 2018-09-06 | 2018-09-06 | 一种具有降血脂功能的口服液的制作方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109430862A true CN109430862A (zh) | 2019-03-08 |
Family
ID=65530319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811036616.9A Withdrawn CN109430862A (zh) | 2018-09-06 | 2018-09-06 | 一种具有降血脂功能的口服液的制作方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109430862A (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102550285A (zh) * | 2012-01-09 | 2012-07-11 | 元拓(福州)生物技术有限公司 | 一种食药用菌菌丝球的制备方法及其产品 |
| CN106913593A (zh) * | 2017-02-19 | 2017-07-04 | 哈尔滨伟平科技开发有限公司 | 一种猴头菇养胃口服液及其制作方法 |
-
2018
- 2018-09-06 CN CN201811036616.9A patent/CN109430862A/zh not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102550285A (zh) * | 2012-01-09 | 2012-07-11 | 元拓(福州)生物技术有限公司 | 一种食药用菌菌丝球的制备方法及其产品 |
| CN106913593A (zh) * | 2017-02-19 | 2017-07-04 | 哈尔滨伟平科技开发有限公司 | 一种猴头菇养胃口服液及其制作方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103099089B (zh) | 一种降糖、降压、通便减肥、抗疲劳、改善性功能保健品及其生产工艺 | |
| CN100551254C (zh) | 甘薯果酱及其制作技术 | |
| CN103054113B (zh) | 一种具有降血糖功效的复合果蔬汁饮料 | |
| CN101010090A (zh) | 糖尿病预防·改善剂以及糖尿病的预防·改善用功能性食品 | |
| CN104287013A (zh) | 一种降血脂降血糖功能性保健醋饮料及其生产工艺 | |
| CN102726565A (zh) | 荞菊养生茶及其制备方法 | |
| CN109315576A (zh) | 纳豆竹叶黄酮压片糖果 | |
| CN106901118A (zh) | 具有辅助降血糖作用的固体饮料及其制备方法 | |
| CN108391785A (zh) | 一种功能性代餐粉及其制作工艺与应用 | |
| CN109430839A (zh) | 一种果蔬全餐冲剂及其制作方法 | |
| CN108174951A (zh) | 一种辅助降血糖的桑叶黄精茶制备方法 | |
| CN107252095A (zh) | 复合酵素及其制备方法 | |
| KR101732456B1 (ko) | 3단복합 발효원액 및 그 제조방법 | |
| KR20160141027A (ko) | 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품 | |
| CN1671372A (zh) | 血流改善食品 | |
| CN101884408B (zh) | 一种银杏叶浸提液及其制备方法 | |
| CN112042835A (zh) | 一种具有降血脂作用的非全营养特医食品及其制备方法 | |
| CN109480136A (zh) | 一种刺梨饮料及其制备方法 | |
| CN109700028A (zh) | 适用于肠型ⅰ人群的餐后血糖调节与预防的膳食组合物 | |
| CN109430862A (zh) | 一种具有降血脂功能的口服液的制作方法 | |
| CN103919229B (zh) | 一种安眠定神保健速溶粉 | |
| CN109430631A (zh) | 一种降血脂保健饮料的制作方法 | |
| CN111202197A (zh) | 一种青稞发酵饮料的制备方法及其制备的青稞发酵饮料 | |
| KR20000018977A (ko) | 동아 녹즙 및 그 잔사를 사용하여 제조된 체중 및 혈당 조절용식품조성물 및 그 제조방법 | |
| CN108260818A (zh) | 一种具有降血脂、降血糖、降血压、提高免疫力功能的保健食品及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190308 |